Searched for
NEURODEGENERATIVE DRUG
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Sleeping over 8 hours daily? Senior Neurologist at Apollo Hospitals explains its underlying health issues and potential risksAre you sleeping more than 8 hours? New research has revealed that a study of nearly 500,000 people found a 'sweet spot' of 6.4 to 7.8 hour...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...
- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...
- Suven Life gets patent from New Zealand for neurological drugSuven Life said it has been granted "one product patent from New Zealand corresponding to the NCEs for the treatment of disorders associate...
- Breakthrough using atomic science can treat Alzheimer'sLondon, July 6 (IANS) British researchers have succeeded in revealing the atomic structure of one of the abnormal filaments that lead to Al...
- Suven Life gets patent for anti-neuro degenerative drugSuven Life said it has been granted "one product patent from the US corresponding to the new chemical entities (NCEs) for the treatment of ...
- Suven Life gets patent for neuro-degenerative drugSuven Life Science grabs a patent by Australia for a drug used in the treatment of neuro-degenerative diseases.
- Suven Life gets patent for neuro-degenerative drugSuven Life said it has been granted "one product patent from India corresponding to the New Chemical Entities (NCEs) for the treatment of d...
- Suven Life shares gain on patent rights in foreign countriesSuven Life Sciences shares rose over 1 per cent after the drug firm got patent rights in foreign countries for a neuro-degenerative drug.
- Suven Life gets patent for neurodegenerative drugSuven Life Sciences has been granted a patent each by Europe and Macau for drug used in the treatment of disorders associated with neurodeg...
- Suven Life Sciences gets patents for neurodegenerative drug in Canada and ChinaSuven Life Sciences said it has been granted two patents from Canada and one patent in China for a drug used in the treatment of neurodegen...
- Suven Life gets patents for neurodegenerative drugNeurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
- Suven Life Sciences gets patents from Israel, South Africa and Japan for neurological drugSuven Life Sciences today said it has been granted a patent by Israel, Japan and South Africa for a drug used to treat neuro-degenerative d...
- Suven Life Sciences gets patents for neurodegenerative drugBiopharmaceutical firm Suven Life Sciences said it has been granted one patent each by the US, Israel and Macau for a drug used for neuroge...
- Biopharmaceutical Suven Life Sciences gets patents for neurodegenerative drugWith these new patents for treatment of neurodegenerative diseases, Suven has a total of 18 granted patents from Mexico and 20 from Singapo...
- Suven Life Sciences gets patents for neuro-degenerative drugNeuro-degenerative ailments include Alzheimer's disease, Schizophrenia and Parkinson's disease.
- Suven Life Sciences granted patents for neurodegenerative drugVenkat Jasti said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena.
- Suven gets four new drug molecule patents in four countriesSuven Life Sciences Ltd gets four product patents one each from Australia, Canada, Korea and New Zealand for their new drug molecules (New ...
Load More
